Pharmacologic control of CAR-T cell function using dasatinib

被引:174
作者
Weber, Evan W. [1 ]
Lynn, Rachel C. [1 ]
Sotillo, Elena [1 ]
Lattin, John [1 ]
Xu, Peng [1 ]
Mackall, Crystal L. [1 ,2 ,3 ]
机构
[1] Stanford Univ, Sch Med, Stanford Canc Inst, Stanford, CA 94305 USA
[2] Stanford Univ, Sch Med, Dept Pediat, Stanford, CA 94305 USA
[3] Stanford Univ, Sch Med, Dept Med, Stanford, CA 94305 USA
基金
美国国家卫生研究院;
关键词
BLOOD-BRAIN-BARRIER; KINASE INHIBITOR; SUICIDE GENE; B-CELL; TOXICITIES; THERAPY; LYMPHOCYTES; ACTIVATION; MANAGEMENT; SYSTEM;
D O I
10.1182/bloodadvances.2018028720
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
[No abstract available]
引用
收藏
页码:711 / 717
页数:7
相关论文
共 27 条
[21]   Phosphoproteomic analysis of chimeric antigen receptor signaling reveals kinetic and quantitative differences that affect cell function [J].
Salter, Alexander I. ;
Ivey, Richard G. ;
Kennedy, Jacob J. ;
Voillet, Valentin ;
Rajan, Anusha ;
Alderman, Eva J. ;
Voytovich, Uliana J. ;
Lin, Chenwei ;
Sommermeyer, Daniel ;
Liu, Lingfeng ;
Whiteaker, Jeffrey R. ;
Gottardo, Raphael ;
Paulovich, Amanda G. ;
Riddell, Stanley R. .
SCIENCE SIGNALING, 2018, 11 (544)
[22]   Dasatinib, a small-molecule protein tyrosine kinase inhibitor, inhibits T-cell activation and proliferation [J].
Schade, Andrew E. ;
Schieven, Gary L. ;
Townsend, Robert ;
Jankowska, Anna M. ;
Susulic, Vojkan ;
Zhang, Rosemary ;
Szpurka, Hadrian ;
Maciejewski, Jaroslaw P. .
BLOOD, 2008, 111 (03) :1366-1377
[23]   Monocyte lineage-derived IL-6 does not affect chimeric antigen receptor T-cell function [J].
Singh, Nathan ;
Hofmann, Ted J. ;
Gershenson, Zachary ;
Levine, Bruce L. ;
Grupp, Stephan A. ;
Teachey, David T. ;
Barrett, David M. .
CYTOTHERAPY, 2017, 19 (07) :867-880
[24]   Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy [J].
Sotillo, Elena ;
Barrett, David M. ;
Black, Kathryn L. ;
Bagashev, Asen ;
Oldridge, Derek ;
Wu, Glendon ;
Sussman, Robyn ;
Lanauze, Claudia ;
Ruella, Marco ;
Gazzara, Matthew R. ;
Martinez, Nicole M. ;
Harrington, Colleen T. ;
Chung, Elaine Y. ;
Perazzelli, Jessica ;
Hofmann, Ted J. ;
Maude, Shannon L. ;
Raman, Pichai ;
Barrera, Alejandro ;
Gill, Saar ;
Lacey, Simon F. ;
Melenhorst, Jan J. ;
Allman, David ;
Jacoby, Elad ;
Fry, Terry ;
Mackall, Crystal ;
Barash, Yoseph ;
Lynch, Kristen W. ;
Maris, John M. ;
Grupp, Stephan A. ;
Thomas-Tikhonenko, Andrei .
CANCER DISCOVERY, 2015, 5 (12) :1282-1295
[25]   Identification of Predictive Biomarkers for Cytokine Release Syndrome after Chimeric Antigen Receptor T-cell Therapy for Acute Lymphoblastic Leukemia [J].
Teachey, David T. ;
Lacey, Simon F. ;
Shaw, Pamela A. ;
Melenhorst, J. Joseph ;
Maude, Shannon L. ;
Frey, Noelle ;
Pequignot, Edward ;
Gonzalez, Vanessa E. ;
Chen, Fang ;
Finklestein, Jeffrey ;
Barrett, David M. ;
Weiss, Scott L. ;
Fitzgerald, Julie C. ;
Berg, Robert A. ;
Aplenc, Richard ;
Callahan, Colleen ;
Rheingold, Susan R. ;
Zheng, Zhaohui ;
Rose-John, Stefan ;
White, Jason C. ;
Nazimuddin, Farzana ;
Wertheim, Gerald ;
Levine, Bruce L. ;
June, Carl H. ;
Porter, David L. ;
Grupp, Stephan A. .
CANCER DISCOVERY, 2016, 6 (06) :664-679
[26]   CD19 CAR-T cells of defined CD4+: CD8+ composition in adult B cell ALL patients [J].
Turtle, Cameron J. ;
Hanafi, Laila-Aicha ;
Berger, Carolina ;
Gooley, Theodore A. ;
Cherian, Sindhu ;
Hudecek, Michael ;
Sommermeyer, Daniel ;
Melville, Katherine ;
Pender, Barbara ;
Budiarto, Tanya M. ;
Robinson, Emily ;
Steevens, Natalia N. ;
Chaney, Colette ;
Soma, Lorinda ;
Chen, Xueyan ;
Yeung, Cecilia ;
Wood, Brent ;
Li, Daniel ;
Cao, Jianhong ;
Heimfeld, Shelly ;
Jensen, Michael C. ;
Riddell, Stanley R. ;
Maloney, David G. .
JOURNAL OF CLINICAL INVESTIGATION, 2016, 126 (06) :2123-2138
[27]   Profound inhibition of antigen-specific T-cell effector functions by dasatinib [J].
Weichsel, Ralf ;
Dix, Carolin ;
Wooldridge, Linda ;
Clement, Matthew ;
Fenton-May, Angharad ;
Sewell, Andrew K. ;
Zezula, Josef ;
Greiner, Elisabeth ;
Gostick, Emma ;
Price, David A. ;
Einsele, Hermann ;
Seggewiss, Ruth .
CLINICAL CANCER RESEARCH, 2008, 14 (08) :2484-2491